Logan University Health Centers Partner with Arete Healthcare to Expand Patient Access and Modernize Care
Logan University Health Centers and Arete Healthcare Partner to Expand Patient Access and Modernize Clinical Care Logan University Health Centers has announced a strategic partnership with Arete Healthcare aimed at…
Agenus Reports Deep Pathologic Responses and No Recurrences in Updated NEST Phase 2 Colon Cancer Data
Agenus Reports Updated NEST Phase 2 Results Supporting Neoadjuvant BOT+BAL in Colon Cancer Agenus Inc. (Nasdaq: AGEN), a biotechnology company focused on immuno-oncology innovation, has announced the peer-reviewed publication of…
OnMed CareStation™ Expands U.S. Reach as States Deploy $50 Billion Rural Health Transformation Funding
OnMed CareStation Gains Momentum as States Deploy $50 Billion Rural Health Transformation Funding As states across the United States transition from planning to implementation of approximately $50 billion in federal…
TRexBio Reports Positive Phase 1a Results for TRB-061, a TNFR2 Agonist for Atopic Dermatitis
TRex Bio Reports Positive Phase 1a Results for TRB-061, Supporting Treg Activation in Atopic Dermatitis TRex Bio, Inc. (TRexBio), a clinical-stage biotechnology company focused on tissue regulatory T-cell (Treg) biology…
Cardio Diagnostics Study Highlights Widening Rural Cardiovascular Care Gap Amid Workforce and Access Challenges
Cardio Diagnostics Releases Updated Rural Health Report Focused on Improving Cardiovascular Care and Access Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an artificial intelligence-driven precision cardiovascular medicine company, has released an…
New Neurology Study Strengthens Evidence for Quantitative MRI Biomarkers in SBMA Muscle Assessment
New Study in Neurology Highlights the Potential of Quantitative MRI Biomarkers for Assessing Muscle Changes in SBMA AMRA Medical has announced the publication of new research in Neurology demonstrating the…
BeOne Medicines Receives FDA Approval for TEVIMBRA-Based First-Line HER2+ GEA Regimen
BeOne Medicines Receives FDA Approval for TEVIMBRA Combination in First-Line HER2-Positive Gastroesophageal Cancer BeOne Medicines Ltd., a global oncology-focused biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA)…
McKesson Agrees to Acquire Precision Medicine Group
McKesson to Acquire Precision Medicine Group for Approximately $2.25 Billion to Expand Oncology and Biopharma Services McKesson Corporation (NYSE: MCK) has announced a definitive agreement to acquire Precision Medicine Group,…
Lōkahi Therapeutics Initiates Clinical Manufacturing for LT-100
Lōkahi Therapeutics Begins GMP Manufacturing of LT-100 for Potential Osteoarthritis Pain Treatment Lōkahi Therapeutics Inc., a subsidiary of Glucotrack, Inc. (NASDAQ: GCTK), has announced the initiation of its initial Good…
Catalent Completes Debt Refinancing to Support Growth and Innovation
Catalent Completes $4.7 Billion Debt Refinancing to Strengthen Financial Position and Support Long-Term Growth Catalent, Inc., a global contract development and manufacturing organization (CDMO) serving the pharmaceutical, biotechnology and healthcare…
Vyome Holdings Reports Q2 2026 Results, Highlighting VT-1953 Progress and Pipeline Expansion
Vyome Holdings Reports Second-Quarter 2026 Results and Highlights Progress Across Clinical Pipeline Vyome Holdings, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for immuno-inflammatory and rare diseases, has announced…
Axoft Launches Fleuron® WISE, Expanding Its Advanced Polymer Portfolio
Axoft Introduces Fleuron WISE Elastomer to Enable High-Resolution Imaging in Aqueous Environments Axoft, a neurotechnology company developing advanced materials and technologies for applications at the intersection of biology and electronics,…